GLP3-R + Cagrilintide Blend
Price Range
Price varies
Vendors
0
Views
5
Where to Buy
Compare GLP3-R + Cagrilintide Blend prices across verified vendors. Affiliate links support Pushing Peptides.
We're gathering pricing data for GLP3-R + Cagrilintide Blend. Check back soon.
Overview
This blend combines Retatrutide (GLP3-R) with Cagrilintide, pairing a triple-agonist GIP/GLP-1/glucagon peptide with a long-acting amylin analog. The combination targets four distinct metabolic pathways simultaneously, representing one of the most comprehensive multi-receptor approaches in metabolic research.
Mechanism of Action
Retatrutide provides GIP, GLP-1, and glucagon receptor activation for appetite reduction, insulin sensitization, and hepatic fat oxidation. Cagrilintide adds amylin receptor agonism, which slows gastric emptying, suppresses glucagon secretion, and reduces food intake through hindbrain satiety centers. The four-pathway combination addresses appetite, insulin dynamics, energy expenditure, and gastric motility.
Research Context
This blend is inspired by Novo Nordisk's clinical development of CagriSema (cagrilintide + semaglutide), which showed exceptional weight loss results in trials. Substituting retatrutide for semaglutide adds glucagon receptor activity to the combination.
Key Research Areas
Considerations for Researchers
Small vendor base (10 vendors) reflects the novelty of this combination. Verify exact component ratios. Higher price point. Store at -20C.
Disclaimer: All information on this page is for research purposes only and is not intended as medical advice. Peptide research should be conducted by qualified professionals in appropriate laboratory settings. Pushing Peptides does not sell peptides. We aggregate publicly available pricing and vendor data.